AI Reshapes Pharma Compliance With Real-Time Monitoring

Pharmaceutical companies are embedding AI directly into manufacturing operations as a real-time compliance layer, moving away from retrospective audits and manual oversight. AI-driven systems now continuously monitor, validate and optimize production to meet tightening Good Manufacturing Practice standards. This Pharma 4.0 shift sees AI, robotics and biotechnology converging to build next-generation infrastructure. Companies including Oncotelic Therapeutics, NVIDIA, Amazon, Honeywell and Omnicell are among those leading adoption of intelligent, automated compliance frameworks as regulators worldwide intensify expectations around data integrity and traceability.